24M-13445-28566
1 vaccination
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 781 / TX
- Registered
- 2021-06-24
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Timeline
-
2021-06-24
Registered in v-safe
-
2021-06-24
Dose 1 — Pfizer-BioNTechCo-administered: yes
-
2021-06-24
Survey response — day 0, dose 1MedDRA: Dizziness, Syncope — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Dizzy, faintMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-06-26
- 2021-06-27
- 2021-06-30
- 2021-07-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-24 | Pfizer-BioNTech | Yes |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Dizzy, faint
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release